Risk of Acute Myocardial Infarction Among Patients With Laboratory-Confirmed Invasive Pneumococcal Disease: A Self-Controlled Case Series Study
- PMID: 36751004
- PMCID: PMC10273377
- DOI: 10.1093/cid/ciad065
Risk of Acute Myocardial Infarction Among Patients With Laboratory-Confirmed Invasive Pneumococcal Disease: A Self-Controlled Case Series Study
Abstract
Background: Acute myocardial infarction (AMI) events have been reported among patients with certain viral and bacterial infections. Whether invasive pneumococcal disease (IPD) increases the risk of AMI remains unclear. We examined whether laboratory-confirmed IPD was associated with the risk of AMI.
Methods: We conducted a self-controlled case series analysis among adult Tennessee residents with evidence of an AMI hospitalization (2003-2019). Patient follow-up started 1 year before the earliest AMI and continued through the date of death, 1 year after AMI, or study end (December 2019). Periods for AMI assessment included the 7 to 1 days before IPD specimen collection (pre-IPD detection), day 0 through day 7 after IPD specimen collection (current IPD), day 8 to 28 after IPD specimen collection (post-IPD), and a control period (all other follow-up). We used conditional Poisson regression to calculate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for each risk period compared with control periods using within-person comparisons.
Results: We studied 324 patients hospitalized for AMI with laboratory-confirmed IPD within 1 year before or after the AMI hospitalization. The incidence of AMI was significantly higher during the pre-IPD detection (IRR, 10.29; 95% CI: 6.33-16.73) and the current IPD (IRR, 92.95; 95% CI: 72.17-119.71) periods but nonsignificantly elevated in the post-IPD risk period (IRR, 1.83; 95% CI: .86-3.91) compared with control periods. The AMI incidence was higher in the post-IPD control period (29 to 365 days after IPD; IRR, 2.95; 95% CI: 2.01-4.32).
Conclusions: Hospitalizations with AMI were strongly associated with laboratory-confirmed IPD.
Keywords: acute myocardial infarction; invasive pneumococcal disease; self-controlled case series.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. C. G. G. reports consulting fees and participation on a data and safety monitoring or advisory board from Merck, research support from the Campbell Alliance/Syneos Health, and grants or contracts from NIH, CDC, Agency for Healthcare Research and Quality, US Food and Drug Administration, and Campbell Alliance/Syneos Health. A. D. W. reports consulting fees from the Tennessee Department of Health and grants from NIH. W. S. serves as the medical director for the National Foundation for Infectious Diseases. H. K. T. and T. M. M. report grants or contracts from the CDC paid to their institution. All remaining authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures
Comment in
-
Risk of Acute Myocardial Infarction Following Invasive Pneumococcal Disease: How Much Is Due to Antibiotic Treatments?Clin Infect Dis. 2023 Jul 26;77(2):330. doi: 10.1093/cid/ciad176. Clin Infect Dis. 2023. PMID: 36975109 No abstract available.
-
Response to Rezahosseini and Barrella Harboe.Clin Infect Dis. 2023 Jul 26;77(2):330-331. doi: 10.1093/cid/ciad180. Clin Infect Dis. 2023. PMID: 36976273 Free PMC article. No abstract available.
References
-
- Mechanic O, Gavin M, Grossman S. Acute myocardial infarction. StatPearls, Treasure Island, FL: StatPearls Publishing, 2022.
-
- Musher DM, Abers MS, Corrales-Medina VF. Acute infection and myocardial infarction. N Engl J Med 2019; 380:171–6. - PubMed
-
- Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012; 125:773–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
